Judge Approves Bayer's $7.25 Billion Roundup Cancer Settlement

A Missouri state court judge has approved Bayer's $7.25 billion settlement of lawsuits alleging that its Roundup weedkiller causes cancer, The Guardian reported. Judge Timothy Boyer, sitting in St. Louis, found the settlement "fair, reasonable and adequate."
Bayer had faced approximately 65,000 claims in U.S. state and federal courts. Plaintiffs alleged that cancer followed Roundup use at home or at work. The settlement, announced in February, aims to resolve nearly all current and future U.S. Roundup claims, though it excludes some pending federal lawsuits. About 200 federal cases are still being litigated.
The company has a long history with the dispute. Bayer bought Monsanto, which produces Roundup, for $63 billion in 2018. It later settled much of the litigation for $10.9 billion in 2020. A separate $1.25 billion proposal to resolve future Roundup claims did not win court approval.
A related ruling came from the U.S. Supreme Court. In a 7-2 decision, the justices overturned a $1.25 million jury award to John Durnell, a Missouri man who blamed Roundup exposure for non-Hodgkin lymphoma. The court agreed with Bayer that federal pesticide law barred failure-to-warn claims brought under state law, which are claims that a product's labeling should have carried a warning.
Bayer chief executive Bill Anderson said the court's final approval was a decisive milestone in limiting the risks posed by pending and future Roundup litigation. The company has maintained that Roundup and its active ingredient, glyphosate, are safe and do not cause cancer.


